Global implementation of these standards will “allow for meaningful comparison between health care systems, evaluation of clinical practice guidelines, and improvement of patient care for people experiencing heart valve disease worldwide,” according to a Feb. 17 news release from the American Heart Association.
The standard’s five outcome domains are vital status, patient-reported outcomes, progression of the disease, cardiac function and durability, and complications of treatment.
The 16 outcome measures selected to be tracked within these domains are all-cause mortality, quality of life, mental health, impact on mental health and daily activities, hospitalization for heart failure, native valve dysfunction, cardiac symptoms, cardiac rhythm, left ventricular ejection fraction, endocarditis, valve thrombosis, bleeding event, stroke and thromboembolic event, operative complications, reoperation and post-intervention valve deterioration.
Experts said clinic-reported measures should be tracked six months to a year after diagnosis, and annually thereafter. Patient-reported outcomes should also be tracked annually and more frequent tracking is advised for patients who have undergone surgical or transcatheter procedures, the release said.
Read the full guideline recommendations here.
Leave a Reply